Septooptic Dysplasia with an Associated Arachnoid Cyst

Skyler V McLaurin-Jiang1, Julie K Wood2, David F Crudo3

  • 1Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Case Reports in Pediatrics
|November 29, 2016
PubMed

Insights

Septo-optic dysplasia (SOD) is a rare condition diagnosed in an infant with hypopituitarism and optic nerve hypoplasia. Early hormone replacement therapy improved the infant's metabolic and thermoregulatory functions.

Area of Science:

  • Pediatric Endocrinology
  • Neuro-ophthalmology
  • Developmental Pediatrics

Background:

  • Septo-optic dysplasia (SOD) is a congenital disorder characterized by the triad of optic nerve hypoplasia, midline brain abnormalities, and pituitary hormone deficiencies.
  • Patients often present with a spectrum of endocrine dysfunctions, including hypopituitarism, and visual impairments.
  • Arachnoid cysts are occasionally associated with SOD, highlighting the complexity of midline developmental abnormalities.

Purpose of the Study:

  • To report a case of septo-optic dysplasia (SOD) in a neonate presenting with multiple endocrine abnormalities and optic nerve hypoplasia.
  • To emphasize the diagnostic challenges and the importance of thorough clinical evaluation and neuroimaging in suspected cases of SOD.
  • To illustrate the positive impact of timely hormone replacement therapy on clinical outcomes in infants with SOD.

Main Methods:

  • Case report of a 4-week-old male infant with hypothermia, hypoglycemia, and hyperbilirubinemia.
  • Physical examination revealed dysmorphic features including retrognathia, hypotonia, micropenis, and clinodactyly.
  • Diagnostic workup included ophthalmologic examination, laboratory tests for hormone levels, and brain magnetic resonance imaging (MRI).

Main Results:

  • Ophthalmologic exam revealed bilateral optic nerve hypoplasia (ONH).
  • Laboratory findings indicated inadequate cortisol and growth hormone response, low thyroxine, and direct hyperbilirubinemia.
  • Brain MRI showed anterior pituitary hypoplasia, absent posterior pituitary bright spot, thin pituitary stalk, and bilateral ONH, confirming SOD diagnosis.
  • Hormone replacement therapy with hydrocortisone and levothyroxine led to significant clinical improvement.

Conclusions:

  • This case underscores the critical role of detailed physical examination and laboratory assessment in identifying SOD, especially in infants with pre-existing conditions like arachnoid cysts.
  • Early diagnosis and initiation of appropriate hormone replacement are crucial for managing the endocrine and metabolic derangements associated with SOD.
  • The association of arachnoid cysts with ONH and hypopituitarism warrants consideration in the diagnostic workup of midline brain abnormalities.